Maternal Transferred Immunity against SARS-CoV-2 (COVID-19) in Neonates
A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Coronaviruses (CoV) and COVID-19 Pandemic".
Deadline for manuscript submissions: closed (10 November 2021) | Viewed by 422
Special Issue Editor
2. Department of Food Science, University of Massachusetts Amherst, Amherst, MA 01003, USA
Interests: premature infant; neonate; COVID-19; SARS-CoV-2; antibodies; pathogens; adaptive immune cells; infectious diseases; breastfeeding; immunization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mothers provide passive immunity to their newborns through the transplacental transfer of antibodies and breast milk intake, which contains secretory IgA, IgA, IgM, IgG, immune cells, and other bioactive proteins. These maternal immune components are critical for the prevention of infectious diseases in neonates. Coronavirus disease 19 (COVID-19) caused more than 71,000 infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant women in the United States alone since February 2021. The approved COVID-19 vaccine is now available for pregnant and lactating women to enhance their immunity against SARS-CoV-2. However, there is a lack of knowledge on how maternal factors influence the efficacity of the COVID-19 vaccine and whether antibodies will be transferred to infants via human milk for lactating women or umbilical cord blood for pregnant women.
This Special Issue of Healthcare will focus on the impact on the maternal immunity acquired from COVID-19 natural infection or immunization (COVID-19 vaccine) on infants' outcomes. The research topic is focused on (1) maternal factors on the potential influence on immune response during COVID-19 vaccine; (2) risk of COVID-19 infection in breastfed infants versus bovine formula-fed infants; and (3) passive immunity during natural infection and immunization of SARS-CoV-2. This Special issue can include original research and reviews, short reports, opinions from researchers, and epidemiological and animal studies.
Dr. Veronique Demers-Mathieu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- SARS-CoV-2
- infectious diseases
- passive immunity
- immunization
- breastfeeding
- systemic immunity
- mucosal response
- neonatal nutrition
- antibodies.
